| GOplot: an R package for visually combining expression data with functional analysis W Walter, F Sánchez-Cabo, M Ricote Bioinformatics 31 (17), 2912-2914, 2015 | 1331 | 2015 |
| Phagocytosis imprints heterogeneity in tissue-resident macrophages N A-Gonzalez, JA Quintana, S García-Silva, M Mazariegos, ... Journal of Experimental Medicine 214 (5), 1281-1296, 2017 | 234 | 2017 |
| Sequential Notch activation regulates ventricular chamber development G D’Amato, G Luxán, G del Monte-Nieto, B Martínez-Poveda, C Torroja, ... Nature cell biology 18 (1), 7-20, 2016 | 187 | 2016 |
| Personalized prediction model to risk stratify patients with myelodysplastic syndromes A Nazha, R Komrokji, M Meggendorfer, X Jia, N Radakovich, J Shreve, ... Journal of Clinical Oncology 39 (33), 3737, 2021 | 106 | 2021 |
| Deciphering the dynamic transcriptional and post-transcriptional networks of macrophages in the healthy heart and after myocardial injury W Walter, L Alonso-Herranz, V Trappetti, I Crespo, M Ibberson, ... Cell reports 23 (2), 622-636, 2018 | 54 | 2018 |
| How artificial intelligence might disrupt diagnostics in hematology in the near future W Walter, C Haferlach, N Nadarajah, I Schmidts, C Kühn, W Kern, ... Oncogene 40 (25), 4271-4280, 2021 | 53 | 2021 |
| Mechanisms of antigen escape from BCMA-or GPRC5D-targeted immunotherapies in multiple myeloma H Lee, S Ahn, R Maity, N Leblay, B Ziccheddu, M Truger, M Chojnacka, ... Nature medicine 29 (9), 2295-2306, 2023 | 45 | 2023 |
| Complex landscape of alternative splicing in myeloid neoplasms CE Hershberger, DC Moyer, V Adema, CM Kerr, W Walter, S Hutter, ... Leukemia 35 (4), 1108-1120, 2021 | 44 | 2021 |
| Single-and double-hit events in genes encoding immune targets before and after T cell–engaging antibody therapy in MM MS Truger, J Duell, X Zhou, L Heimeshoff, A Ruckdeschel, M John, ... Blood advances 5 (19), 3794-3798, 2021 | 38 | 2021 |
| The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time? A Höllein, SO Twardziok, W Walter, S Hutter, C Baer, ... Cancer genetics 242, 15-24, 2020 | 37 | 2020 |
| IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies M Meggendorfer, LV Cappelli, W Walter, C Haferlach, W Kern, B Falini, ... Leukemia 32 (5), 1249-1253, 2018 | 34 | 2018 |
| Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies A Stengel, C Baer, W Walter, M Meggendorfer, W Kern, T Haferlach, ... Blood advances 5 (21), 4426-4434, 2021 | 33 | 2021 |
| Artificial intelligence in hematological diagnostics: Game changer or gadget? W Walter, C Pohlkamp, M Meggendorfer, N Nadarajah, W Kern, ... Blood Reviews 58, 101019, 2023 | 31 | 2023 |
| Whole transcriptome sequencing detects a large number of novel fusion transcripts in patients with AML and MDS A Stengel, R Shahswar, T Haferlach, W Walter, S Hutter, M Meggendorfer, ... Blood Advances 4 (21), 5393-5401, 2020 | 31 | 2020 |
| Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia S Kimura, L Montefiori, I Iacobucci, Y Zhao, Q Gao, EM Paietta, ... Blood, The Journal of the American Society of Hematology 139 (24), 3519-3531, 2022 | 28 | 2022 |
| Next-generation diagnostics for precision oncology: Preanalytical considerations, technical challenges, and available technologies W Walter, N Pfarr, M Meggendorfer, P Jost, T Haferlach, W Weichert Seminars in cancer biology 84, 3-15, 2022 | 25 | 2022 |
| Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies M Sakuma, P Blombery, M Meggendorfer, C Haferlach, M Lindauer, ... Leukemia 37 (5), 1080-1091, 2023 | 24 | 2023 |
| A personalized prediction model to risk stratify patients with myelodysplastic syndromes A Nazha, RS Komrokji, M Meggendorfer, S Mukherjee, N Al Ali, W Walter, ... Blood 132, 793, 2018 | 23 | 2018 |
| Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia W Walter, R Shahswar, A Stengel, M Meggendorfer, W Kern, T Haferlach, ... BMC cancer 21, 1-11, 2021 | 21 | 2021 |
| Risk prediction in MDS: independent validation of the IPSS-M—ready for routine? C Baer, S Huber, S Hutter, M Meggendorfer, N Nadarajah, W Walter, ... Leukemia 37 (4), 938-941, 2023 | 16 | 2023 |
